Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Significance of serum carcinoembryonic antigen despite normal preoperative levels in colorectal cancer patients receiving curative resection

Date

19 Dec 2015

Session

Poster presentation 1

Presenters

Seung-Hoon Beom

Citation

Annals of Oncology (2015) 26 (suppl_9): 42-70. 10.1093/annonc/mdv523

Authors

S. Beom, M. Jung, S.J. Shin, S.Y. Rha, H.C. Chung, J.B. Ahn

Author affiliations

  • Internal Medicine, Yonsei Cancer Center Yonsei University, 120-752 - Seoul/KR
More

Resources

Abstract 1337

Aim/Background

We evaluated preoperative serum carcinoembryonic antigen (CEA) as a prognostic factor for colorectal cancer patients with normal range of CEA, and determined when surveillance of this marker was useful.

Methods

We carried out a retrospective cohort study in CRC patients with normal CEA level (< 5.0 ng/mL) before curative transabdominal resection between January 2005 and June 2012 in Yonsei Cancer Center, and those were followed up with intensive surveillance program. Serum CEA was measured preoperatively in 1,473 patients who underwent surgery, and measured at 3-month intervals for the first 2 postoperative years and at 6-month intervals thereafter up to 5 years.

Results

The 5-year disease-free survival (DFS) rate and overall survival rate were significantly lower in patients with high normal preoperative serum CEA (> 3.0 ng/mL) level (P = 0.033 and 0.025). High normal preoperative serum CEA level was an independent poor prognostic factor for tumor recurrence by multivariate analysis (P = 0.033). In subgroup analysis by tumor–node–metastasis (TNM) stage revealed a lower DFS in patients with high normal preoperative CEA in stage III, while that was not significant in stage I or II. Among patients with a tumor recurrence (N = 190), 52 (27.4%) patients had abnormal serum CEA level (> 5 ng/mL) at recurrence. CEA elevation above normal range at recurrence was observed more frequently in patients with high normal preoperative CEA level. In stage III patients with high normal preoperative serum CEA level, CEA surveillance had a 62.5% positive predictive value (PPV) and an 81.8% negative predictive value (NPV).

Conclusions

High serum CEA level (> 3.0 ng/mL) was an independent prognostic factor for colorectal cancer even in patients with normal range of CEA preoperatively. Postoperative serum CEA surveillance was used most effectively when patients had high normal preoperative serum CEA levels and pathologic stage III.

Clinical trial identification

Disclosure

All authors have declared no conflicts of interest.

Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings